tumor microenvironment

Melbourne, Australia – August 27, 2026 Propanc Biopharma announced new preclinical and early translational data for PRP in pancreatic...

San Diego, California, August 14, 2026 BioSapien Inc., a biotechnology company developing localized drug-delivery technologies for cancer treatment, has...

LONDON, Boston & Budapest, July 2, 2026 Treos Bio announced new translational findings from its Phase Ib/II OBERTO-301 clinical...

LUND, Sweden, June 27, 2026 Cantargia AB announced the publication of new preclinical and clinical findings in JCI Insight,...

SAN DIEGO, June 24, 2026 Calidi Biotherapeutics presented new preclinical data on CLD-501, its investigational in situ T-cell engager...

WALTHAM, Mass. | May 28, 2026 BostonGene announced that nine abstracts have been accepted for presentation at the 2026...

TARRYTOWN, N.Y., May 21, 2026 Sapience Therapeutics has announced encouraging updated clinical data from its ongoing Phase 2 trial...

San Diego, California, USA, April 6, 2026 FDA Engagement Signals Registrational Pathway Progress In a key development for oncolytic...

DENVER, USA – March 18, 2026 TriSalus Life Sciences has announced new preclinical findings demonstrating that its Pressure-Enabled Drug...

SUZHOU, China, Feb. 15, 2026 — CStone Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Investigational...